Skin Implant Metastasis After Percutaneous Radio-Frequency Therapy of Liver Metastasis of a Colorectal Carcinoma

Bonatti, H.; Bodner, G.; Obrist, P.; Bechter, O.; Wetscher, G.; Oefner, D.
September 2003
American Surgeon;Sep2003, Vol. 69 Issue 9, p763
Academic Journal
Percutaneous radio-frequency ablation (RFA) of liver tumors has been reported to be an effective approach. Skin implant metastases have been described after RFA of hepatocellular carcinoma. A 56-year-old man underwent resection of the transverse colon for an adenocarcinoma (pT3N2M0) following by adjuvant chemotherapy. He developed multiple liver metastases and underwent RFA. Six weeks after RFA, the patient noticed a painful skin lesion at the entrance side of the probe in the right upper abdominal quadrant. Ultrasound examination and computed tomography scan revealed an intracutaneous tumor of 2-cm diameter. The tumor was excised and revealed a metastasis of the previously described adenocarcinoma. CPT-11 monotherapy was started; however, due to tumor progression, the patient died 35 months after colonic resection and 10 months after RFA. This is the first case of an implant skin metastasis after RFA of secondary liver tumors. Although RFA is a promising option in the palliation of such tumors, such rare complications have to be considered.


Related Articles

  • Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria. Lei, Jianyong; Wang, Wentao; Yan, Lunan // Journal of Gastrointestinal Surgery;Aug2013, Vol. 17 Issue 8, p1440 

    Background and Aims: Many hepatocellular carcinoma (HCC) patients met the appropriate criteria and accepted liver transplantation after successful downstaging therapies; however, the outcome in these patients is unclear. We aim to compare the outcome of patients meeting the Milan criteria at the...

  • New therapies for hepatocellular carcinoma. Avila, M. A.; Berasain, C.; Sangro, B.; Prieto, J. // Oncogene;6/26/2006, Vol. 25 Issue 27, p3866 

    Hepatocellular carcinoma (HCC), one of the most common cancers worldwide, is often diagnosed at an advanced stage when most potentially curative therapies such as resection, transplantation or percutaneous and transarterial interventions are of limited efficacy. The fact that HCC is resistant to...

  • Liver Transplantation Exceeding UCSF Criteria: Case Report of a Late Recurrence Treated by Surgery and Review of the Literature. Piardi, T.; Audet, M.; Odeh, M.; Panaro, F.; Cag, M.; El-ahmar, J.; Baiocchi, G. L.; Schneider, A.; Wolf, P. // European Surgical Research;2010, Vol. 44 Issue 1, p52 

    Introduction: Treatment of a recurrence of hepatocellular carcinoma (HCC) after liver transplantation. Surgery has seldom been considered in such a situation because HCC recurrences are generally considered as a systemic disease. Patient and Methods: We describe a 47-year-old male patient who...

  • Chapter 41: THE LIVER.  // Understanding Surgery;2001, p168 

    The article focuses on the surgery of the liver. Several surgical procedures for liver diseases are used by surgeons. A simple cyst of the liver can be aspirated and drained under local anesthesia. Abscesses and complex cysts require an open surgical operation. If there is massive bleeding...

  • Expression of multidrug resistance protein in metastatic colorectal carcinomas. Nanashima, Atsushi; Yamaguchi, Hiroyuki; Matsuo, Seiji; Sumida, Yorihisa; Tsuji, Takashi; Sawai, Terumitsu; Yasutake, Toru; Nakagoe, Tohru; Ayabe, Hiroyoshi; Nanashima, A; Yamaguchi, H; Matsuo, S; Sumida, Y; Tsuji, T; Sawai, T; Yasutake, T; Nakagoe, T; Ayabe, H // Journal of Gastroenterology;1999, Vol. 34 Issue 5, p582 

    To clarify the relationship between multidrug resistance protein (MRP) and clinicopathologic features, the influence of adjuvant chemotherapy, and prognosis of patients who underwent resection of metastatic liver carcinomas originating from colorectal carcinomas, we examined the expression of...

  • Ablation of Hepatic Malignancies: From Radiofrequency to Microwave-A New Generation of Technology. Bilchik, Anton J. // Journal of Interventional Oncology;2009, Vol. 2 Issue 2, p121 

    Primary and metastatic hepatic malignancies are often a terminal event because few patients are candidates for hepatic resection or transplantation. Comorbidities, poor biology, and tumor location may preclude resection, and although hepatic transplantation may be curative in patients with...

  • Observation may be reasonable for Bosniak III cysts. Wildasin, Kathleen // Urology Times;5/15/2005, Vol. 33 Issue 6, p33 

    Reports on a research which claims that watchful waiting may be a reasonable alternative to surgery in patients with Bosniak III renal cysts who have multiple comorbidities and are of advanced age. Characteristics of Bosniak III renal cysts; Development of the five-category Bosniak...

  • Mantle's transplant raises delicate issues about organ allocation. Randal, Judith // JNCI: Journal of the National Cancer Institute;4/17/96, Vol. 88 Issue 8, p484 

    Part I. Examines the use of liver transplants in the treatment of liver cancer. Controversy on the liver transplant done on the late baseball player Mickey Mantle; Publicity factor in liver transplants; Priorities for liver transplantation.

  • Liver transplant may be an option for some patients with unresectable HCC.  // Hem/Onc Today;10/10/2012, Vol. 13 Issue 19, p19 

    The article discusses research being done on patients who received transplants because of unresectable non-cirrhotic hepatocellular carcinoma.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics